Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study

Bai H, Wang WH, Zhou FF, Yang D, Li RJ

Cancer Management and Research 2024, 16:73-86

Published Date: 1 February 2024